01:26 , Nov 28, 2017 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Malaria Cell culture and human sample studies identified combinations of Plasmodium falciparum antigens that could be used to develop a malaria vaccine. In a human erythrocyte-based assay of P. falciparum growth, polyclonal rabbit IgGs against...
14:57 , Mar 8, 2017 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Malaria Cell culture and rabbit studies identified a modified P. falciparum Rh5-derived peptide that could be used in malaria vaccines. The peptide consisted of a synthetic 116 amino-acid fragment of the P. falciparum Rh5 N-terminus...
01:47 , Feb 2, 2017 |  BC Innovations  |  Distillery Therapeutics

Infectious disease

INDICATION: Malaria In vitro and cell culture studies identified a thermally stable P. falciparum Rh5 variant that could be used in malaria vaccines. The variant consisted of a C-terminal fragment of wild-type P. falciparum Rh5 engineered...
08:00 , Dec 1, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Infectious disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Infectious disease Malaria Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRh5); basigin Ok blood group (BSG; EMMPRIN; CD147) In...